People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Other, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Stationhead, Inc. | — | Other | Series A | $18.5M | $124.8M | 2021 |
| LifeVault Bio, Inc. | — | Biotech / Pharma | Series B | $17.9M | $595.3M | 2020 |
Avi Ellman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Avi Ellman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| A. Andrew Levison | 1 | 4 |
| Bill Wesemann | 1 | 3 |
| Anthony Bay | 1 | 3 |
| Brad Hamilton | 1 | 2 |
| David Scadden | 1 | 2 |
| Ryan Kulchinsky | 1 | 2 |
| Trevor Perry | 1 | 1 |
| Andrew McInnes | 1 | 1 |
| Salvatore Siino | 1 | 1 |
| Kevin Sarney | 1 | 1 |
| Dan Marshak | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.